No exits recorded yet.
0 funds tracked, 0 portfolio companies (0 active · 0 realized). Verified weekly from public filings and deal announcements.
Carl Bennet AB is a major Swedish family investment holding with net asset value of approximately SEK 100-107 billion (~€9-10 billion) as of December 2024 (group net sales SEK 86.3 billion in 2024), headquartered in Gothenburg and wholly owned by Carl Bennet. The holding company structure consolidated through the 1990s after Carl Bennet acquired Getinge in 1989, with Lifco taken private in 2000. Portfolio companies operate across approximately 50 countries with approximately 33,400 employees.
Carl Bennet AB deploys permanent family capital through long-term controlling ownership of listed industrial and medtech companies, with the develop-businesses-for-the-global-market philosophy. The concentrated holding tracks 3 core listed stakes (Lifco at approximately 81% of NAV, Getinge approximately 10%, Elanders approximately 1%) plus Arjo and other securities. Sector focus spans healthcare and medical technology, dental, engineering and industrials and logistics and supply-chain services. Geographic deployment is Sweden-based with portfolio companies operating globally, and Lifco itself a prolific industrial serial acquirer.
Consistent with the buy-and-hold posture, no material divestments occurred across 2024-2026. Recent acquisitions include an increased stake in medical technology (Getinge, 2024), an increased stake in medical technology (Arjo, 2025) and ongoing Lifco bolt-on industrial acquisitions throughout 2024-2025 (approximately 8 per year). The platform continues active long-term ownership across the concentrated industrial and medtech holdings. Detailed buyer names and multiple data available on Pro at €49/month.
Other private equity firms tracked on GP Intel.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in